Salomonsky Henry Louis 13D and 13G filings for Immune Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-12-15 4:48 pm Purchase |
2022-07-25 | 13D | Immune Therapeutics, Inc. IMUN |
Salomonsky Henry Louis | 12,168,900 14.700% |
12,168,900 (New Position) |
Filing |